Answers are grounded in this paper and cite their sources.
Many clinical trials that are based on the efficacy demonstrated in preclinical models fail to achieve the expected outcome.The preclinical models used include mainly cell cultures and animal models.Also, in the last few years, 3-dimensional (3D)-like formations, such as spheroids and organoids, are being used.A unique ex vivo organ culture to elucidate the mechanism of action and efficacy of new drugs was recently reported.However, its usage is not yet widespread.In previous work, we reported the selectivity of oncolytic viruses in a model of cancerous colorectal tissue.In this study, we evaluated the relevance of this model in comparison to conventional cell cultures.To this end, we conducted a bioinformatics analysis of gene expression in various colorectal cancer cell lines and compared them to the gene expression of colorectal cancer tissues obtained from 32 patients.The results showed that the expression of genes, including those directly related to colorectal cancer progression, varied significantly between the different cell lines.In contrast, in tissues that originated from patients, gene expression was more consistent.The results from this analysis highlight the need to carefully choose a cell line that reflects the transcript of the human tissue to be studied.Furthermore, we conclude that bioinformatics analysis might be a useful tool for determining the most appropriate experimental model.The use of organ cultures directly derived from patients might be a more accurate model to evaluate the efficacy of a given therapy.
No takes yet. Share an insight, caveat, or question.
Tayeb et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: